ARTICLE | Clinical News
CHS-131: Phase IIb data
July 11, 2016 7:00 AM UTC
Top-line data from a double-blind Phase IIb trial in 227 treatment-naive patients with RRMS showed that once-daily 3 mg oral CHS-131 met the primary endpoint of reducing the cumulative number of total...